Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea flag South Korea · Delayed Price · Currency is KRW
16,230
+30 (0.19%)
At close: Apr 29, 2026

Cell Biotech Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
17,1394,7577,8848,4589,860
Upgrade
Short-Term Investments
75,92374,45056,51537,67118,675
Upgrade
Trading Asset Securities
-8,2475,93319,23929,299
Upgrade
Cash & Short-Term Investments
93,06287,45470,33265,36857,834
Upgrade
Cash Growth
6.41%24.34%7.59%13.03%5.37%
Upgrade
Accounts Receivable
4,3573,9914,5954,5664,664
Upgrade
Other Receivables
736.95682.88943.86583.11268.43
Upgrade
Receivables
5,3624,9765,7405,3305,216
Upgrade
Inventory
4,6164,2034,1224,1023,589
Upgrade
Prepaid Expenses
459.01287.27691.85500.5292.5
Upgrade
Other Current Assets
214.29228.191,044354.58587.81
Upgrade
Total Current Assets
103,71297,14881,92975,65567,519
Upgrade
Property, Plant & Equipment
30,46030,46332,93733,63834,057
Upgrade
Long-Term Investments
501.94501.94501.943,7868,427
Upgrade
Other Intangible Assets
1,1761,6061,5991,7931,536
Upgrade
Long-Term Accounts Receivable
00000
Upgrade
Long-Term Deferred Tax Assets
270.14216.96182.29449.3751.56
Upgrade
Other Long-Term Assets
452.94461.66491.37517.21585.15
Upgrade
Total Assets
136,572130,398117,641115,839112,877
Upgrade
Accounts Payable
458.36680.27578.391,3701,224
Upgrade
Accrued Expenses
395.45481.51489.15443.91470.95
Upgrade
Current Portion of Leases
350.13650.28621.14600.78402.89
Upgrade
Current Income Taxes Payable
187.231,404-1,038814.73
Upgrade
Current Unearned Revenue
33.2727.5727.0330.950.44
Upgrade
Other Current Liabilities
3,4362,6193,1063,9052,802
Upgrade
Total Current Liabilities
4,8615,8634,8217,3895,766
Upgrade
Long-Term Leases
75.25366.66934.17357.79423.49
Upgrade
Other Long-Term Liabilities
0---0
Upgrade
Total Liabilities
4,9366,2295,7557,7476,189
Upgrade
Common Stock
4,7004,7004,7004,7004,700
Upgrade
Additional Paid-In Capital
12,76012,76012,76012,76012,760
Upgrade
Retained Earnings
137,309130,264118,217114,993109,894
Upgrade
Treasury Stock
-23,978-23,978-23,978-23,978-20,258
Upgrade
Comprehensive Income & Other
845.33422.69186.4-382.91-408.42
Upgrade
Shareholders' Equity
131,637124,168111,885108,092106,687
Upgrade
Total Liabilities & Equity
136,572130,398117,641115,839112,877
Upgrade
Total Debt
425.381,0171,555958.57826.38
Upgrade
Net Cash (Debt)
92,63686,43768,77764,40957,007
Upgrade
Net Cash Growth
7.17%25.68%6.78%12.98%6.47%
Upgrade
Net Cash Per Share
13531.5212628.3210049.379342.068061.43
Upgrade
Filing Date Shares Outstanding
6.856.846.846.847.07
Upgrade
Total Common Shares Outstanding
6.856.846.846.847.07
Upgrade
Working Capital
98,85291,28677,10868,26661,754
Upgrade
Book Value Per Share
19210.9318142.9416348.1715793.9115086.68
Upgrade
Tangible Book Value
130,461122,563110,286106,299105,151
Upgrade
Tangible Book Value Per Share
19039.3617908.3116114.5315531.8814869.49
Upgrade
Land
9,6969,6969,7659,7659,765
Upgrade
Buildings
22,29619,67519,53713,34913,854
Upgrade
Machinery
26,32225,84725,6447,2288,033
Upgrade
Construction In Progress
117.7385.42338.95993.9247.26
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.